Estrogen receptor coregulators and pioneer factors: The orchestrators of mammary gland cell fate and development

Frontiers in Cell and Developmental Biology

Volumn 2, Issue AUG, 2014, Pages

  Manavathi, Bramanandam ^a   Samanthapudi, Venkata S K ^a   Gajulapalli, Vijay Narasimha Reddy ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

Coregulators; Estrogen; Estrogen receptor; Mammary gland development; Pioneer factors

Indexed keywords

EID: 84929578747     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2014.00034     Document Type: Review

References (123)

1. Asselin-Labat, M. L., Sutherland, K. D., Barker, H., Thomas, R., Shackleton, M., Forrest, N. C., et al. (2007). Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9, 201-209. doi: 10.1038/ncb1530
2. Asselin-Labat, M. L., Vaillant, F., Sheridan, J. M., Pal, B., Wu, D., Simpson, E. R., et al. (2010). Control of mammary stem cell function by steroid hormone signalling. Nature 465, 798-802. doi: 10.1038/nature09027
3. Bagheri-Yarmand, R., Talukder, A. H., Wang, R. A., Vadlamudi, R. K., and Kumar, R. (2004). Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis. Development 131, 3469-3479. doi: 10.1242/dev.01213
4. Bernardo, G. M., Lozada, K. L., Miedler, J. D., Harburg, G., Hewitt, S. C., Mosley, J. D., et al. (2010). FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development 137, 2045-2054. doi: 10.1242/dev.043299
5. Brisken, C., Heineman, A., Chavarria, T., Elenbaas, B., Tan, J., Dey, S. K., et al. (2000). Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 14, 650-654. doi: 10.1101/gad.14.6.650
6. Brisken, C., and O'malley, B. (2010). Hormone action in the mammary gland. Cold Spring Harb. Perspect. Biol. 2, a003178. doi: 10.1101/cshperspect.a003178
7. Buckley, N. E., Conlon, S. J., Jirstrom, K., Kay, E. W., Crawford, N. T., O'grady, A., et al. (2011). The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer. Cancer Res. 71, 1933-1944. doi: 10.1158/0008-5472.CAN-10-2717
8. Caizzi, L., Ferrero, G., Cutrupi, S., Cordero, F., Ballare, C., Miano, V., et al. (2014). Genome-wide activity of unliganded estrogen receptor-alpha in breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 111, 4892-4897. doi: 10.1073/pnas.1315445111
9. Carr, J. R., Kiefer, M. M., Park, H. J., Li, J., Wang, Z., Fontanarosa, J., et al. (2012). FoxM1 regulates mammary luminal cell fate. Cell Rep. 1, 715-729. doi: 10.1016/j.celrep.2012.05.005
10. Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., et al. (2005). Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33-43. doi: 10.1016/j.cell.2005.05.008
11. Casimiro, M. C., Wang, C., Li, Z., Di Sante, G., Willmart, N. E., Addya, S., et al. (2013). Cyclin D1 determines estrogen signaling in the mammary gland in vivo. Mol. Endocrinol. 27, 1415-1428. doi: 10.1210/me.2013-1065
12. Castet, A., Boulahtouf, A., Versini, G., Bonnet, S., Augereau, P., Vignon, F., et al. (2004). Multiple domains of the receptor-interactingprotein 140 contribute to transcription inhibition. Nucleic Acids Res. 32, 1957-1966. doi: 10.1093/nar/gkh524
13. Catoe, H. W., and Nawaz, Z. (2011). E6-AP facilitates efficient transcription at estrogen responsive promoters through recruitment of chromatin modifiers. Steroids 76, 897-902. doi: 10.1016/j.steroids.2011.04.007
14. Cavailles, V., Dauvois, S., L'horset, F., Lopez, G., Hoare, S., Kushner, P. J., et al. (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741-3751
15. Chen, D., Huang, S. M., and Stallcup, M. R. (2000). Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300. J. Biol. Chem. 275, 40810-40816. doi: 10.1074/jbc.M005459200
16. Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S. M., Schurter, B. T., et al. (1999). Regulation of transcription by a protein methyltransferase. Science 284, 2174-2177
17. Chowdhury, I., Thompson, W. E., and Thomas, K. (2014). Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway. J. Cell. Physiol. 229, 998-1004. doi: 10.1002/jcp.24531
18. Dasgupta, S., Lonard, D. M., and O'malley, B. W. (2014). Nuclear receptor coactivators: master regulators of human health and disease. Annu. Rev. Med. 65, 279-292. doi: 10.1146/annurev-med-051812-145316
19. Davidson, E. H., and Erwin, D. H. (2006). Gene regulatory networks and the evolution of animal body plans. Science 311, 796-800. doi: 10.1126/science.1113832
20. Delage-Mourroux, R., Martini, P. G., Choi, I., Kraichely, D. M., Hoeksema, J., and Katzenellenbogen, B. S. (2000). Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. J. Biol. Chem. 275, 35848-35856. doi: 10.1074/jbc.M001327200
21. Eakin, C. M., Maccoss, M. J., Finney, G. L., and Klevit, R. E. (2007). Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase. Proc. Natl. Acad. Sci. U.S.A. 104, 5794-5799. doi: 10.1073/pnas.0610887104
22. Echeverria, P. C., and Picard, D. (2010). Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility. Biochim. Biophys. Acta 1803, 641-649. doi: 10.1016/j.bbamcr.2009.11.012
23. Ewan, K. B., Shyamala, G., Ravani, S. A., Tang, Y., Akhurst, R., Wakefield, L., et al. (2002). Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am. J. Pathol. 160, 2081-2093. doi: 10.1016/S0002-9440(10)61158-3
24. Fan, S., Ma, Y. X., Wang, C., Yuan, R. Q., Meng, Q., Wang, J. A., et al. (2001). Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 20, 77-87. doi: 10.1038/sj.onc.1204073
25. Fan, S., Ma, Y. X., Wang, C., Yuan, R. Q., Meng, Q., Wang, J. A., et al. (2002). p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res. 62, 141-151
26. Fan, S., Wang, J., Yuan, R., Ma, Y., Meng, Q., Erdos, M. R., et al. (1999). BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284, 1354-1356
27. Fantl, V., Edwards, P. A., Steel, J. H., Vonderhaar, B. K., and Dickson, C. (1999). Impaired mammary gland development in Cyl-1(-/-) mice during pregnancy and lactation is epithelial cell autonomous. Dev. Biol. 212, 1-11. doi: 10.1006/dbio.1999.9329
28. Feng, Y., Manka, D., Wagner, K. U., and Khan, S. A. (2007). Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc. Natl. Acad. Sci. U.S.A. 104, 14718-14723. doi: 10.1073/pnas.0706933104
29. Fujita, N., Jaye, D. L., Kajita, M., Geigerman, C., Moreno, C. S., and Wade, P. A. (2003). MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113, 207-219. doi: 10.1016/S0092-8674(03)00234-4
30. Fullwood, M. J., Liu, M. H., Pan, Y. F., Liu, J., Xu, H., Mohamed, Y. B., et al. (2009). An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 462, 58-64. doi: 10.1038/nature08497
31. Gao, X., Mohsin, S. K., Gatalica, Z., Fu, G., Sharma, P., and Nawaz, Z. (2005). Decreased expression of e6-associated protein in breast and prostate carcinomas. Endocrinology 146, 1707-1712. doi: 10.1210/en.2004-1198
32. Gehin, M., Mark, M., Dennefeld, C., Dierich, A., Gronemeyer, H., and Chambon, P. (2002). The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol. Cell. Biol. 22, 5923-5937. doi: 10.1128/MCB.22.16.5923-5937.2002
33. Gertz, J., Reddy, T. E., Varley, K. E., Garabedian, M. J., and Myers, R. M. (2012). Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 22, 2153-2162. doi: 10.1101/gr.135681.111
34. Gorski, J. J., Kennedy, R. D., Hosey, A. M., and Harkin, D. P. (2009). The complex relationship between BRCA1 and ERalpha in hereditary breast cancer. Clin. Cancer Res. 15, 1514-1518. doi: 10.1158/1078-0432.CCR-08-0640
35. Han, S. J., Lonard, D. M., and O'malley, B. W. (2009). Multi-modulation of nuclear receptor coactivators through posttranslational modifications. Trends Endocrinol. Metab. 20, 8-15. doi: 10.1016/j.tem.2008.10.001
36. Hasegawa, N., Sumitomo, A., Fujita, A., Aritome, N., Mizuta, S., Matsui, K., et al. (2012). Mediator subunits MED1 and MED24 cooperatively contribute to pubertal mammary gland development and growth of breast carcinoma cells. Mol. Cell. Biol. 32, 1483-1495. doi: 10.1128/MCB.05245-11
37. He, B., Feng, Q., Mukherjee, A., Lonard, D. M., Demayo, F. J., Katzenellenbogen, B. S., et al. (2008). A repressive role for prohibitin in estrogen signaling. Mol. Endocrinol. 22, 344-360. doi: 10.1210/me.2007-0400
38. Heery, D. M., Kalkhoven, E., Hoare, S., and Parker, M. G. (1997). A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736. doi: 10.1038/42750
39. Ho, I. C., and Pai, S. Y. (2007). GATA-3-not just for Th2 cells anymore. Cell Mol. Immunol. 4, 15-29
40. Hosey, A. M., Gorski, J. J., Murray, M. M., Quinn, J. E., Chung, W. Y., Stewart, G. E., et al. (2007). Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. J. Natl. Cancer Inst. 99, 1683-1694. doi: 10.1093/jnci/djm207
41. Howlin, J., Mcbryan, J., Napoletano, S., Lambe, T., Mcardle, E., Shioda, T., et al. (2006). CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis. Oncogene 25, 1532-1542. doi: 10.1038/sj.onc.1209183
42. Hu, X., and Lazar, M. A. (1999). The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402, 93-96. doi: 10.1038/47069
43. Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D., and Carroll, J. S. (2011). FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 43, 27-33. doi: 10.1038/ng.730
44. Jiang, P., Hu, Q., Ito, M., Meyer, S., Waltz, S., Khan, S., et al. (2010). Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 107, 6765-6770. doi: 10.1073/pnas.1001814107
45. Jozwik, K. M., and Carroll, J. S. (2012). Pioneer factors in hormone-dependent cancers. Nat. Rev. Cancer 12, 381-385. doi: 10.1038/nrc3263
46. Kawai, H., Li, H., Chun, P., Avraham, S., and Avraham, H. K. (2002). Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene 21, 7730-7739. doi: 10.1038/sj.onc.1205971
47. Klein-Hitpass, L., Ryffel, G. U., Heitlinger, E., and Cato, A. C. (1988). A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res. 16, 647-663
48. Klinge, C. M. (2000). Estrogen receptor interaction with co-activators and co-repressors. Steroids 65, 227-251. doi: 10.1016/S0039-128X(99)00107-5
49. Kong, S. L., Li, G., Loh, S. L., Sung, W. K., and Liu, E. T. (2011). Cellular reprogramming by the conjoint action of ERa, FOXA1, and GATA3 to a ligand-inducible growth state. Mol. Syst. Biol. 30, 526. doi: 10.1038/msb.2011.59
50. Kouros-Mehr, H., Kim, J. W., Bechis, S. K., and Werb, Z. (2008). GATA-3 and the regulation of the mammary luminal cell fate. Curr. Opin. Cell Biol. 20, 164-170. doi: 10.1016/j.ceb.2008.02.003
51. Kouros-Mehr, H., Slorach, E. M., Sternlicht, M. D., and Werb, Z. (2006). GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127, 1041-1055. doi: 10.1016/j.cell.2006.09.048
52. Kumar, R., Balasenthil, S., Pakala, S. B., Rayala, S. K., Sahin, A. A., and Ohshiro, K. (2010). Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells. Cancer Res. 70, 6598-6608. doi: 10.1158/0008-5472.CAN-10-0907
53. Kumar, R., Wang, R. A., Mazumdar, A., Talukder, A. H., Mandal, M., Yang, Z., et al. (2002). A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature 418, 654-657. doi: 10.1038/nature00889
54. Lamb, J., Ladha, M. H., Mcmahon, C., Sutherland, R. L., and Ewen, M. E. (2000). Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol. Cell. Biol. 20, 8667-8675. doi: 10.1128/MCB.20.23.8667-8675.2000
55. Lieberman-Aiden, E., Van Berkum, N. L., Williams, L., Imakaev, M., Ragoczy, T., Telling, A., et al. (2009). Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326, 289-293. doi: 10.1126/science.1181369
56. Lonard, D. M., Lanz, R. B., and O'malley, B. W. (2007). Nuclear receptor coregulators and human disease. Endocr. Rev. 28, 575-587. doi: 10.1210/er.2007-0012
57. Lonard, D. M., and O'malley, B. W. (2006). The expanding cosmos of nuclear receptor coactivators. Cell 125, 411-414. doi: 10.1016/j.cell.2006.04.021
58. Lonard, D. M., and O'malley, B. W. (2007). Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol. Cell 27, 691-700. doi: 10.1016/j.molcel.2007.08.012
59. Magnani, L., Ballantyne, E. B., Zhang, X., and Lupien, M. (2011a). PBX1 genomic pioneer function drives ERalpha signaling underlying progression in breast cancer. PLoS Genet. 7:e1002368. doi: 10.1371/journal.pgen.1002368
60. Magnani, L., Eeckhoute, J., and Lupien, M. (2011b). Pioneer factors: directing transcriptional regulators within the chromatin environment. Trends Genet. 27, 465-474. doi: 10.1016/j.tig.2011.07.002
61. Malik, S., Guermah, M., Yuan, C. X., Wu, W., Yamamura, S., and Roeder, R. G. (2004). Structural and functional organization of TRAP220, the TRAP/mediator subunit that is targeted by nuclear receptors. Mol. Cell. Biol. 24, 8244-8254. doi: 10.1128/MCB.24.18.8244-8254.2004
62. Mallepell, S., Krust, A., Chambon, P., and Brisken, C. (2006). Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 103, 2196-2201. doi: 10.1073/pnas.0510974103
63. Manavathi, B., and Kumar, R. (2007). Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J. Biol. Chem. 282, 1529-1533. doi: 10.1074/jbc.R600029200
64. Manavathi, B., Dey, O., Gajulapalli, V. N., Bhatia, R. S., Bugide, S., and Kumar, R. (2013). Derailed estrogen signaling and breast cancer: an authentic couple. Endocr. Rev. 34, 1-32. doi: 10.1210/er.2011-1057
65. Manavathi, B., Peng, S., Rayala, S. K., Talukder, A. H., Wang, M. H., Wang, R. A., et al. (2007). Repression of Six3 by a corepressor regulates rhodopsin expression. Proc. Natl. Acad. Sci. U.S.A. 104, 13128-13133. doi: 10.1073/pnas.0705878104
66. Martini, P. G., Delage-Mourroux, R., Kraichely, D. M., and Katzenellenbogen, B. S. (2000). Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol. Cell. Biol. 20, 6224-6232. doi: 10.1128/MCB.20.17.6224-6232.2000
67. Mazumdar, A., Wang, R. A., Mishra, S. K., Adam, L., Bagheri-Yarmand, R., Mandal, M., et al. (2001). Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat. Cell Biol. 3, 30-37. doi: 10.1038/35050532
68. Mcinerney, E. M., Rose, D. W., Flynn, S. E., Westin, S., Mullen, T. M., Krones, A., et al. (1998). Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 12, 3357-3368
69. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71
70. Millour, J., Constantinidou, D., Stavropoulou, A. V., Wilson, M. S., Myatt, S. S., Kwok, J. M., et al. (2010). FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance. Oncogene 29, 2983-2995. doi: 10.1038/onc.2010.47
71. Mishra, S. K., Balasenthil, S., Nguyen, D., and Vadlamudi, R. K. (2004). Cloning and functional characterization of PELP1/MNAR promoter. Gene 330, 115-122. doi: 10.1016/j.gene.2004.01.011
72. Misiti, S., Schomburg, L., Yen, P. M., and Chin, W. W. (1998). Expression and hormonal regulation of coactivator and corepressor genes. Endocrinology 139, 2493-2500. doi: 10.1210/endo.139.5.5971
73. Montano, M. M., Ekena, K., Delage-Mourroux, R., Chang, W., Martini, P., and Katzenellenbogen, B. S. (1999). An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc. Natl. Acad. Sci. U.S.A. 96, 6947-6952
74. Mueller, S. O., Clark, J. A., Myers, P. H., and Korach, K. S. (2002). Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinology 143, 2357-2365. doi: 10.1210/endo.143.6.8836
75. Mukherjee, A., Soyal, S. M., Fernandez-Valdivia, R., Gehin, M., Chambon, P., Demayo, F. J., et al. (2006). Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse. Mol. Cell. Biol. 26, 6571-6583. doi: 10.1128/MCB.00654-06
76. Mussi, P., Liao, L., Park, S. E., Ciana, P., Maggi, A., Katzenellenbogen, B. S., et al. (2006). Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 103, 16716-16721. doi: 10.1073/pnas.0607768103
77. Naresh, A., Long, W., Vidal, G. A., Wimley, W. C., Marrero, L., Sartor, C. I., et al. (2006). The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Res. 66, 6412-6420. doi: 10.1158/0008-5472.CAN-05-2368
78. Nautiyal, J., Christian, M., and Parker, M. G. (2013). Distinct functions for RIP140 in development, inflammation, and metabolism. Trends Endocrinol. Metab. 24, 451-459. doi: 10.1016/j.tem.2013.05.001
79. Nawaz, Z., Lonard, D. M., Smith, C. L., Lev-Lehman, E., Tsai, S. Y., Tsai, M. J., et al. (1999). The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19, 1182-1189
80. Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., et al. (2001). Mechanisms of estrogen action. Physiol. Rev. 81, 1535-1565
81. Nishihara, E., Yoshida-Komiya, H., Chan, C. S., Liao, L., Davis, R. L., O'malley, B. W., et al. (2003). SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells. J. Neurosci. 23, 213-222
82. O'malley, B. W., and Mckenna, N. J. (2008). Coactivators and corepressors: what's in a name? Mol. Endocrinol. 22, 2213-2214. doi: 10.1210/me.2008-0201
83. O'malley, B. W., Qin, J., and Lanz, R. B. (2008). Cracking the coregulator codes. Curr. Opin. Cell Biol. 20, 310-315. doi: 10.1016/j.ceb.2008.04.005
84. Onate, S. A., Tsai, S. Y., Tsai, M. J., and O'malley, B. W. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357
85. Ormandy, C. J., Musgrove, E. A., Hui, R., Daly, R. J., and Sutherland, R. L. (2003). Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res. Treat. 78, 323-335. doi: 10.1023/A:1023033708204
86. Park, S., Zhao, Y., Yoon, S., Xu, J., Liao, L., Lydon, J., et al. (2011). Repressor of estrogen receptor activity (REA) is essential for mammary gland morphogenesis and functional activities: studies in conditional knockout mice. Endocrinology 152, 4336-4349. doi: 10.1210/en.2011-1100
87. Rajan, J. V., Marquis, S. T., Gardner, H. P., and Chodosh, L. A. (1997). Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev. Biol. 184, 385-401. doi: 10.1006/dbio.1997.8526
88. Ramamoorthy, S., and Nawaz, Z. (2008). E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors. Nucl. Recept. Signal. 6, e006. doi: 10.1621/nrs.06006
89. Ramamoorthy, S., Tufail, R., Hokayem, J. E., Jorda, M., Zhao, W., Reis, Z., et al. (2012). Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. Breast Cancer Res. Treat. 132, 97-108. doi: 10.1007/s10549-011-1567-2
90. Raouf, A., Zhao, Y., To, K., Stingl, J., Delaney, A., Barbara, M., et al. (2008). Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 3, 109-118. doi: 10.1016/j.stem.2008.05.018
91. Regan, J. L., Kendrick, H., Magnay, F. A., Vafaizadeh, V., Groner, B., and Smalley, M. J. (2012). c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer. Oncogene 31, 869-883. doi: 10.1038/onc.2011.289
92. Rokicki, J., Das, P. M., Giltnane, J. M., Wansbury, O., Rimm, D. L., Howard, B. A., et al. (2010). The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium. Mol. Cancer 9, 150. doi: 10.1186/1476-4598-9-150
93. Rosen, J. M. (2012). On murine mammary epithelial stem cells: discovery, function, and current status. Cold Spring Harb. Perspect. Biol. 4, a013268. doi: 10.1101/cshperspect.a013268
94. Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., et al. (2012). Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389-393. doi: 10.1038/nature10730
95. Russo, J., and Russo, I. H. (2004). Development of the human breast. Maturitas 49, 2-15. doi: 10.1016/j.maturitas.2004.04.011
96. Safe, S. (2001). Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm. 62, 231-252. doi: 10.1016/S0083-6729(01)62006-5
97. Sanyal, A., Lajoie, B. R., Jain, G., and Dekker, J. (2012). The long-range interaction landscape of gene promoters. Nature 489, 109-113. doi: 10.1038/nature11279
98. Schuur, E. R., Mcpherson, L. A., Yang, G. P., and Weigel, R. J. (2001). Genomic structure of the promoters of the human estrogen receptor-alpha gene demonstrate changes in chromatin structure induced by AP2gamma. J. Biol. Chem. 276, 15519-15526. doi: 10.1074/jbc.M009001200
99. Sekiya, T., Muthurajan, U. M., Luger, K., Tulin, A. V., and Zaret, K. S. (2009). Nucleosome-binding affinity as a primary determinant of the nuclear mobility of the pioneer transcription factor FoxA. Genes Dev. 23, 804-809. doi: 10.1101/gad.1775509
100. Smith, C. L., Devera, D. G., Lamb, D. J., Nawaz, Z., Jiang, Y. H., Beaudet, A. L., et al. (2002). Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction. Mol. Cell. Biol. 22, 525-535. doi: 10.1128/MCB.22.2.525-535.2002
101. Smith, C. L., and O'malley, B. W. (2004). Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25, 45-71. doi: 10.1210/er.2003-0023
102. Spillman, M. A., and Bowcock, A. M. (1996). BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 13, 1639-1645
103. Srinivasan, K., Strickland, P., Valdes, A., Shin, G. C., and Hinck, L. (2003). Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis. Dev. Cell 4, 371-382. doi: 10.1016/S1534-5807(03)00054-6
104. Stingl, J. (2009). Detection and analysis of mammary gland stem cells. J. Pathol. 217, 229-241. doi: 10.1002/path.2457
105. Sun, J., Zhou, W., Kaliappan, K., Nawaz, Z., and Slingerland, J. M. (2012). ERalpha phosphorylation at Y537 by Src triggers E6-AP-ERalpha binding, ERalpha ubiquitylation, promoter occupancy, and target gene expression. Mol. Endocrinol. 26, 1567-1577. doi: 10.1210/me.2012-1140
106. Tanos, T., Rojo, L. J., Echeverria, P., and Brisken, C. (2012). ER and PR signaling nodes during mammary gland development. Breast Cancer Res. 14, 210. doi: 10.1186/bcr3166
107. Tidcombe, H., Jackson-Fisher, A., Mathers, K., Stern, D. F., Gassmann, M., and Golding, J. P. (2003). Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 100, 8281-8286. doi: 10.1073/pnas.1436402100
108. Tkocz, D., Crawford, N. T., Buckley, N. E., Berry, F. B., Kennedy, R. D., Gorski, J. J., et al. (2012). BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers. Oncogene 31, 3667-3678. doi: 10.1038/onc.2011.531
109. Van Amerongen, R., Bowman, A. N., and Nusse, R. (2012). Developmental stage and time dictate the fate of Wnt/beta-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 11, 387-400. doi: 10.1016/j.stem.2012.05.023
110. Wang, C., Fan, S., Li, Z., Fu, M., Rao, M., Ma, Y., et al. (2005). Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Res. 65, 6557-6567. doi: 10.1158/0008-5472.CAN-05-0486
111. Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. V. (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369, 669-671. doi: 10.1038/369669a0
112. Welboren, W. J., Van Driel, M. A., Janssen-Megens, E. M., Van Heeringen, S. J., Sweep, F. C., Span, P. N., et al. (2009). ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 28, 1418-1428. doi: 10.1038/emboj.2009.88
113. White, J. H., Fernandes, I., Mader, S., and Yang, X. J. (2004). Corepressor recruitment by agonist-bound nuclear receptors. Vitam. Horm. 68, 123-143. doi: 10.1016/S0083-6729(04)68004-6
114. Williams, C. C., Allison, J. G., Vidal, G. A., Burow, M. E., Beckman, B. S., Marrero, L., et al. (2004). The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J. Cell Biol. 167, 469-478. doi: 10.1083/jcb.200403155
115. Xiao, R., Sun, D., Ayers, S., Xi, Y., Li, W., Baxter, J. D., et al. (2012). Research resource: the estrogen receptor alpha cistrome defined by DamIP. Mol. Endocrinol. 26, 349-357. doi: 10.1210/me.2011-1080
116. Xu, J., Liao, L., Ning, G., Yoshida-Komiya, H., Deng, C., and O'malley, B. W. (2000). The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. U.S.A. 97, 6379-6384. doi: 10.1073/pnas.120166297
117. Xu, J., Qiu, Y., Demayo, F. J., Tsai, S. Y., Tsai, M. J., and O'malley, B. W. (1998). Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279, 1922-1925
118. Xu, X., Wagner, K. U., Larson, D., Weaver, Z., Li, C., Ried, T., et al. (1999). Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet. 22, 37-43. doi: 10.1038/8743
119. Yahata, T., Shao, W., Endoh, H., Hur, J., Coser, K. R., Sun, H., et al. (2001). Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev. 15, 2598-2612. doi: 10.1101/gad.906301
120. Zhang, H., Singh, R. R., Talukder, A. H., and Kumar, R. (2006). Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway. Genes Dev. 20, 2943-2948. doi: 10.1101/gad.1461706
121. Zheng, L., Annab, L. A., Afshari, C. A., Lee, W. H., and Boyer, T. G. (2001). BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 98, 9587-9592. doi: 10.1073/pnas.171174298
122. Zhu, Y., Sullivan, L. L., Nair, S. S., Williams, C. C., Pandey, A. K., Marrero, L., et al. (2006). Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells. Cancer Res. 66, 7991-7998. doi: 10.1158/0008-5472.CAN-05-4397
123. Zwijsen, R. M., Buckle, R. S., Hijmans, E. M., Loomans, C. J., and Bernards, R. (1998). Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev. 12, 3488-3498